First-in-class oral therapeutic to disrupt the natural course of lactose intolerance by stimulating lactose-metabolizing bacteria in the colon and offering long-term symptom relief
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Ritter Pharmaceuticals plus 4810 other startups.